$WAT (Waters Corporation)

$WAT {{ '2016-04-26T17:15:31+0000' | timeago}} • Webcast

$WAT said in the Americas region, the US delivered 2% growth in 1Q16 led by low-teens growth from the US pharmaceutical market. US industrial sales were affected by strong quarterly comparison as well as TA's Discovery system launch. The company expects government and academic sales to ramp later in 2016 as budgets get released.

$WAT {{ '2017-06-22T14:22:15+0000' | timeago}} • Announcement

$WAT announced that Dr. Flemming Ornskov, CEO of Shire plc, has been elected to $WAT’s BoD, effective June 22, 2017.

$WAT {{ '2017-06-15T15:06:19+0000' | timeago}} • Announcement

Andrew Alliance and $WAT signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. $WAT will combine its existing Glycoworks RapiFluor-MS (RFMS) N-Glycan Kits with an Andrew pipetting robot.

$WAT {{ '2017-06-01T13:56:03+0000' | timeago}} • Announcement

RedShift BioAnalytics, Inc. announced the closing of a $11MM Series C Preferred Stock financing, co-led by Technology Venture Partners and $WAT. The Series C financing allows RedShift to accelerate the commercialization of its biotechnology instrument platform in 2017. RedShift also hired Jeffrey Zonderman as Chief Commercial Officer.

$WAT {{ '2017-04-25T12:37:03+0000' | timeago}} • Announcement

$WAT reported a rise in 1Q17 earnings driven by strong 8% sales growth from pharmaceutical market and 5% sales growth from the industrial market. Net income rose to $105.56MM or $1.31 per share from $94.05MM or $1.15 per share last year. Sales grew to $497.97MM from $475.25MM. Adjusted EPS increased to $1.46 from $1.26.

$WAT {{ '2017-01-24T12:19:50+0000' | timeago}} • Announcement

During 4Q16, $WAT's highest geographical growth came from Asia, which posted a 16% constant currency sales growth rate. While sales in the U.S. and Europe, in constant currency, grew 2% and 9% respectively during the quarter.

$WAT {{ '2017-01-24T12:14:12+0000' | timeago}} • Announcement

Analytical systems and software maker $WAT posted a 15.4% growth in its 4Q16 earnings. The company's net income increased to $174.3MM from $151MM during 4Q15. Diluted EPS rose 17% to $2.15 from $1.83 during 4Q15. Net sales increased 7% YoverY to $629MM from $587MM during the prior year period. Excluding items, $WAT earned $2.21 per share.

$WAT {{ '2016-12-08T16:28:45+0000' | timeago}} • Announcement

$WAT appointed Sherry Buck as its CFO and SVP, effective Jan. 9, 2017. Buck replaces Eugene Cassis, $WAT's CFO since February 2014, who will transition to a senior advisory role.

$WAT {{ '2016-10-25T18:32:35+0000' | timeago}} • Webcast

For 4Q16, $WAT expects constant currency sales growth of approx. 5%. GM is expected to be around 60%. Net interest expense is expected to be about $7MM and operating tax rate is expected to be 14%. Adjusted diluted EPS is expected to be $2.08-2.18. For 2016, $WAT expects reported sales growth of about 6% and adjusted diluted EPS of $6.48-6.58.

$WAT {{ '2016-10-25T18:25:56+0000' | timeago}} • Webcast

$WAT's cash and short-term investments totaled $2.7Bil and debt was about $1.8Bil, bringing the net cash position to $931MM. In 3Q16, the company repurchased 440,000 shares for $69MM. Free cash flow came in at $128MM in 3Q16.

$WAT {{ '2016-10-25T18:15:48+0000' | timeago}} • Webcast

$WAT saw sales growth of 4% in Waters Instruments in 3Q16. In the TA Instruments business, revenues were up 1%, with flat sales in instrument systems and 6% growth in service revenues. In Japan, sales from the Waters portfolio declined modestly at constant currency.  The performance of the TA business in Japan was flat.

$WAT {{ '2016-10-25T18:05:19+0000' | timeago}} • Webcast

$WAT said the global industrial sector, which includes sales to the material characterization, food, environmental and fine chemicals market, grew 1% in 3Q16. Global weakness from the chemical industry contributed to slower growth in the TA Instruments and Waters product lines. In food safety and food quality applications, sales grew 7%.

$WAT {{ '2016-10-25T11:52:14+0000' | timeago}} • Announcement

In 3Q16, $WAT saw sales growth of 16% in Asia, with strong demand from China. Sales in Europe fell by 3%, with stronger Western European results, offset by weaker demand from Eastern Europe. Sales in the US decreased by 1%, with pharmaceutical sector growth offset by weaker governmental and academic demand.

$WAT {{ '2016-10-25T11:49:35+0000' | timeago}} • Announcement

In 3Q16, $WAT posted a 13% sales growth from the bio/pharmaceutical market and 2% sales growth from the industrial market, offset by a 15% decline in sales within the governmental and academic markets. Recurring revenues, the combination of service and chemistry consumables, posted 8% sales growth, while instrument system sales grew approx. 3%.

$WAT {{ '2016-10-25T11:46:04+0000' | timeago}} • Announcement

Analytical instruments manufacturer $WAT reported an increase in 3Q16 earnings helped by higher sales. Net income was $124.8MM or $1.53 per share in 3Q16, an increase of 9% compared to 3Q15. Total sales grew 5% to $527MM versus last year.

$WAT {{ '2016-07-26T18:48:11+0000' | timeago}} • Webcast

$WAT said that on the product front, water sales were up 8%, while TA sales were up 10%. Geographically, US sales were up 5% in 2Q16, Europe was up 12%, Japan up 3% and sales in Asia outside of Japan was up 10%. $WAT's cash and short term investment totaled $2.6Bil and debt was about $1.8Bil, bringing the company to a net cash position of $843MM.

$WAT {{ '2016-07-26T18:28:32+0000' | timeago}} • Webcast

$WAT, which competes with $PKI and $TMO, said the company's pharmaceutical market led the way with 12% growth in 2Q16. The company saw good growth in its core small molecule QA/QC as well as in large molecule R&D oriented applications. On product line dynamics, instrument sales grew 7% with positive demand for core LC and bench top LC-MS platforms.

$WAT {{ '2016-07-26T12:35:10+0000' | timeago}} • Announcement

$WAT said results from the company's end markets in 2Q16 were driven by 12% sales growth from its bio/pharmaceutical market and 7% sales growth from its industrial market. Geographically, $WAT's Asia sales rose 9% while Europe increased by 12%. Sales in the U.S. rose by 5% in the quarter.

$WAT {{ '2016-07-26T12:30:16+0000' | timeago}} • Announcement

Analytical systems and software maker $WAT reported a higher quarterly profit, helped by increased demand from its bio/pharmaceutical and industrial end markets. The company reported 2Q16 earnings of $128.2MM, or $1.59 per share, compared with $105.7MM, or $1.28 per share a year ago. Revenue rose 8% to $537MM.

$WAT {{ '2016-06-07T18:52:15+0000' | timeago}} • SEC

$WAT said that 1Q16 effective tax rate was 11.8% vs. 15.3% for 1Q15. The slump in effective tax rate is attributed to a quarter-specific tax benefit associated with modifications to certain stock compensation awards. In addition, the income tax provision for 2015 included a quarter-specific tax provision related to a pending tax audit settlement.

$WAT {{ '2016-06-07T18:51:43+0000' | timeago}} • SEC

During 1Q16, $WAT's net cash provided by operating activities was $160MM vs. 1Q15, up $5MM mainly due to higher sales volumes and timing of payments to vendors & collection of receivables from customers. Within cash flows used in investing activities, CapEx related to property, plant, equipment & software capitalization were $25MM.

Recent Transcripts

GE (General Electric Company)
Friday, July 21 2017 - 12:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
DHR (Danaher Corp.)
Thursday, July 20 2017 - 12:00pm
A (Agilent Technologies Inc.)
Monday, May 22 2017 - 8:30pm
UQM (UQM Technologies Inc.)
Thursday, May 11 2017 - 8:30pm
VRML (Vermillion, Inc.)
Thursday, May 11 2017 - 12:30pm
COHR (Coherent Inc.)
Tuesday, May 9 2017 - 8:30pm
CVU (CPI Aerostructures Inc.)
Tuesday, May 9 2017 - 12:30pm
FLDM (Fluidigm Corporation)
Thursday, May 4 2017 - 9:00pm
PKI (PerkinElmer Inc.)
Thursday, May 4 2017 - 9:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
PSDV (pSivida Corp.)
Thursday, May 4 2017 - 8:30pm
CBMX (CombiMatrix Corporation)
Thursday, May 4 2017 - 8:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
LBY (Libbey Inc.)
Tuesday, May 2 2017 - 3:00pm
TECH (Bio-Techne Corp.)
Tuesday, May 2 2017 - 1:00pm
XYL (Xylem Inc.)
Tuesday, May 2 2017 - 1:00pm
STS (Supreme Industries Inc.)
Monday, May 1 2017 - 1:00pm
F (Ford Motor Co.)
Thursday, April 27 2017 - 1:00pm
PACB (Pacific Biosciences of California, Inc.)
Wednesday, April 26 2017 - 8:30pm

AlphaGraphics you may like